These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7661057)

  • 1. Influence of the selection of angiographic projections on the results of coronary angiographic follow-up trials. International Nifedipine Trial on Antiatherosclerotic Therapy Investigators.
    Jost S; Deckers J; Nikutta P; Reiber JH; Rafflenbeul W; Wiese B; Hecker H; Lichtlen P
    Am Heart J; 1995 Sep; 130(3 Pt 1):433-9. PubMed ID: 7661057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of coronary stenoses is related to baseline severity--a prospective quantitative angiographic analysis in patients with moderate coronary disease. INTACT Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers JW; Nikutta P; Wiese B; Rafflenbeul W; Hecker H; Lippolt P; Lichtlen PR
    Eur Heart J; 1994 May; 15(5):648-53. PubMed ID: 8056005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].
    Jost S; Deckers J; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Lippolt P; Hugenholtz PG; Lichtlen PR
    Z Kardiol; 1989 Jan; 78(1):23-32. PubMed ID: 2646838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Nellessen U; Wiese B; Hugenholtz PG; Lichtlen PR
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1037-45. PubMed ID: 2076391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Jost S; Deckers JW; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Hugenholtz PG; Lichtlen PR
    Int J Card Imaging; 1988; 3(2-3):75-86. PubMed ID: 3049846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Nikutta P; Deckers JW
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1047-68. PubMed ID: 2076392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.
    Jost S; Deckers J; Rafflenbeul W; Reiber JH; Nikutta P; Wiese B; Hecker H; Lippolt P; Riedel M; Nolte CW
    Int J Card Imaging; 1993 Mar; 9(1):29-37. PubMed ID: 8491998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International nifedipine trial on antiatherosclerotic therapy (INTACT).
    Lichtlen PR; Nellessen U; Rafflenbeul W; Jost S; Hecker H
    Cardiovasc Drugs Ther; 1987; 1(1):71-9. PubMed ID: 3154311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators.
    Jost S; Deckers JW; Nikutta P; Rafflenbeul W; Wiese B; Hecker H; Lippolt P; Lichtlen PR
    J Am Coll Cardiol; 1993 May; 21(6):1339-46. PubMed ID: 8473639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative coronary angiography: evidence of a sustained increase in vascular smooth muscle tone in coronary artery stenoses.
    Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1983; 72 Suppl 3():87-91. PubMed ID: 6421019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).
    Blankenhorn DH; Azen SP; Kramsch DM; Mack WJ; Cashin-Hemphill L; Hodis HN; DeBoer LW; Mahrer PR; Masteller MJ; Vailas LI; Alaupovic P; Hirsch LJ;
    Ann Intern Med; 1993 Nov; 119(10):969-76. PubMed ID: 8214993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Deckers JW
    Lancet; 1990 May; 335(8698):1109-13. PubMed ID: 1971861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
    Ouyang P; Tardif JC; Herrington DM; Stewart KJ; Thompson PD; Walsh MN; Bennett SK; Heldman AW; Tayback MA; Wang NY;
    Atherosclerosis; 2006 Dec; 189(2):375-86. PubMed ID: 16442114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.
    Ouyang P; Brinker JA; Mellits ED; Weisfeldt ML; Gerstenblith G
    Circulation; 1984 Sep; 70(3):367-76. PubMed ID: 6378422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.
    Joseph A; Talley JD; Shih A; Crum T; Vogel R; Kupersmith J
    Int J Card Imaging; 1994 Sep; 10(3):217-25. PubMed ID: 7876661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology.
    Kaski JC; Chester MR; Chen L; Katritsis D
    Circulation; 1995 Oct; 92(8):2058-65. PubMed ID: 7554182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.